FPCG
BMY icon

Fort Pitt Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Fort Pitt Capital Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-658,324
Closed -$33.8M – 123
2023
Q4 		$33.8M Sell
658,324
-311,020
-32% -$16.3M 1.11% 34
2023
Q3 		$56.3M Buy
969,344
+88,790
+10% +$5.44M 2.11% 22
2023
Q2 		$56.3M Buy
880,554
+23,919
+3% +$1.6M 2.07% 24
2023
Q1 		$59.4M Buy
856,635
+44,770
+6% +$3.16M 2.29% 17
2022
Q4 		$58.4M Buy
811,865
+12,322
+2% +$929K 2.38% 16
2022
Q3 		$56.8M Buy
799,543
+28,016
+4% +$2.03M 2.61% 11
2022
Q2 		$59.4M Buy
771,527
+12,900
+2% +$982K 2.58% 12
2022
Q1 		$55.4M Buy
758,627
+125,900
+20% +$8.45M 2.07% 23
2021
Q4 		$39.5M Buy
632,727
+72,639
+13% +$4.26M 1.43% 31
2021
Q3 		$33.1M Buy
560,088
+72,494
+15% +$4.77M 1.38% 32
2021
Q2 		$32.6M Buy
487,594
+42,045
+9% +$2.74M 1.32% 30
2021
Q1 		$28.1M Buy
445,549
+27,789
+7% +$1.73M 1.26% 32
2020
Q4 		$25.9M Buy
417,760
+101,113
+32% +$6.22M 1.25% 31
2020
Q3 		$19.1M Buy
316,647
+20,102
+7% +$1.21M 1.06% 34
2020
Q2 		$17.4M Sell
296,545
-22,053
-7% -$1.32M 1.03% 35
2020
Q1 		$17.8M Buy
318,598
+44,476
+16% +$2.72M 1.23% 34
2019
Q4 		$17.6M Buy
274,122
+170,362
+164% +$9.76M 1% 35
2019
Q3 		$5.26M Buy
+103,760
New +$4.88M 0.32% 58
2019
Q2 		– Sell
-5,888
Closed -$281K – 127
2019
Q1 		$281K Sell
5,888
-3,016
-34% -$150K 0.02% 119
2018
Q4 		$463K Buy
8,904
+1,466
+20% +$78.8K 0.04% 103
2018
Q3 		$462K Buy
7,438
+253
+4% +$15K 0.03% 89
2018
Q2 		$398K Buy
7,185
+1,663
+30% +$89.8K 0.03% 90
2018
Q1 		$349K Buy
+5,522
New +$355K 0.03% 96

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fort Pitt Capital Group's BMY Position: Q1 2024 in Review

Fort Pitt Capital Group sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 658,324 shares — an estimated $33.8M sold.

Fort Pitt Capital Group first reported a position in BMY in Q1 2018 and held it in 23 quarters. The position peaked at $59.4M in Q2 2022. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Fort Pitt Capital Group reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Fort Pitt Capital Group sold 658,324 Bristol-Myers Squibb shares in Q1 2024, an estimated $33.8M.
  • Fort Pitt Capital Group first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 23 quarters.
  • Fort Pitt Capital Group's Bristol-Myers Squibb position peaked at $59.4M in Q2 2022.
  • 2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Fort Pitt Capital Group's 13F filing for Q1 2024, filed 11 Apr 2024.